PharmaMedic Announces Expanded Medical Affairs Solutions to Boost Branded Sales from Existing Generic Portfolios
PharmaMedic helps generic manufacturers navigate a growing but challenging market. Click to learn more
Medical Affairs
News Category
5 Trends Shaping Medical Affairs in 2025 — Are You Ready?
As 2024 draws to a close, the question on everyone’s mind is — What’s next for medical affairs in 2025? With the healthcare landscape changing at an unprecedented pace, staying ahead means understanding the trends that will define the year ahead. From digital transformation to patient-centric strategies, these shifts are already reshaping the way medical affairs teams operate. Here’s what you need to know to stay prepared and relevant.
Building Better Care — NHS and Life Sciences Partnerships
A new report from The King’s Fund, NHS and Life Sciences Industry Partnerships: Collaborating to Improve Care, shows how working together can help the NHS improve care. The NHS is under pressure, and joining forces with the life sciences sector could bring in new ideas, tools, and support.
Cut Through the Noise — Elevate Your Medical Affairs Strategy
Healthcare today is more complex than ever. Physicians face a torrent of clinical data, treatment guidelines, and disease-specific updates while managing tight schedules. For pharmaceutical companies, this creates a pressing challenge — how to support healthcare providers (HCPs) in delivering better outcomes without overloading them. Medical affairs teams, with their unique blend of science and clinical insight, are ideally placed to meet this need.
How Digital Opinion Leaders Are Shaping the Future of Medical Affairs
Healthcare is changing, and so is the way people influence it. Authority no longer stays locked in conference rooms or academic journals. Today, Digital Opinion Leaders (DOLs) drive key conversations online. These healthcare professionals shape debates that matter — bringing together peers, patients, and stakeholders in the digital spaces where they spend the most time. If your Medical Affairs strategy hasn’t tapped into the power of these digital voices, you might miss big opportunities to adapt, connect, and improve.
Think Differently — A New Approach to Transforming Medical Affairs in Big Pharma
In the fast-paced world of medical and regulatory affairs, large pharmaceutical companies are under increasing pressure to stay ahead. PharmaMedic Consultancy (PMC) understands this need and offers a flexible, expert-driven solution. With a network of over 100 consultants, PMC provides specialised, outsourced expertise that integrates seamlessly with your team to handle crucial tasks—from launch planning and KOL (Key Opinion Leader) engagement to regulatory compliance and certification.
From Support to Strategy – How Medical Affairs Drives Smarter Drug Development
Medical Affairs in recent times has stepped out of the background to become a core strategic partner in pharma and biotech companies. No longer just a support team, MA is at the forefront — blending science, business, and healthcare to create a development process that is faster and deeply centred on patient needs.
How Omnichannel KOL Engagement Drives Successful Medical Interactions
The pharmaceutical landscape is moving fast, and the importance of omnichannel engagement is becoming clear. Especially when it comes to reaching healthcare professionals (HCPs), and more specifically, Key Opinion Leaders (KOLs). These experts are at the forefront of medical advancements and reaching them in the right way can make all the difference. With the right omnichannel approach, you can build deeper, more meaningful relationships that cater to their unique preferences—helping them make decisions more efficiently in this ever-changing, complex field.
Maximise Success for Generic Manufacturers
The global demand for generic pharmaceuticals is growing, but manufacturers face significant hurdles. Regulatory complexity, market entry barriers, and the need for product differentiation require strategic thinking. At the same time, manufacturers must maintain tight control over costs to succeed.
How-to Drive Patient Impact — Five Strategic Priorities for Medical Affairs
In today’s rapidly evolving healthcare landscape, Medical Affairs (MA) teams have taken on a pivotal role. They are no longer viewed as just support teams but are now essential in improving patient care, expanding access to treatments, and shaping the future of medicine. As healthcare becomes more complex, Medical Affairs is increasingly focusing on putting patients’ needs at the heart of every decision. By concentrating on five key areas, Medical Affairs can improve patient outcomes and strengthen the reputation of pharmaceutical companies.